サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1574985

臨床試験管理システム市場：コンポーネント別、配信モード別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年予測

Clinical Trial Management System Market, By Component, By Delivery Mode, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
臨床試験管理システム市場：コンポーネント別、配信モード別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

臨床試験管理システムの市場規模は、2023年に18億6,054万米ドルとなり、2024年から2032年にかけてCAGR14.98%で拡大

臨床試験管理システム市場 - 市場力学

効率的な治験管理への需要の高まりが臨床試験管理システム市場の拡大を加速

効率的な治験管理に対する需要の高まりが、臨床試験管理システム（CTMS）市場の拡大を大きく加速させています。FDAの報告によると、臨床試験の70%以上が非効率的な管理による遅延に見舞われており、プロセスを合理化するためにCTMSソリューションを採用する企業が増えています。米国立衛生研究所（NIH）も、データ管理と規制順守を強化するための技術統合の重要性を強調しています。Medidata Solutionsのような企業は、自社のプラットフォームが治験コストを最大30%削減できると指摘しており、スポンサーにとって魅力的な選択肢となっています。さらに、Clinical Trials Transformation Initiativeの調査によると、臨床試験関係者の80%が、CTMSを活用することで利害関係者間のコラボレーションが強化され、最終的に患者募集の迅速化と試験結果の改善につながると考えていることが明らかになりました。このような効率化に対する緊急のニーズは、急速に進化する状況の中で競争力を維持するために、ヘルスケア組織をCTMSテクノロジーへの投資に駆り立てています。

臨床試験管理システム市場 - 主要な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約14.98%のCAGRで毎年成長すると推定されています。

コンポーネントのセグメンテーションに基づくと、ソフトウェアセグメントは2023年に最大の市場シェアを示すと予測されました。

配信モード別では、クラウドベースのCTMSが2023年の主要タイプでした。

用途別では、オンコロジーが2023年の主要タイプでした。

地域別では、北米が2023年の収益をリードしています。

臨床試験管理システム市場 - セグメンテーション分析：

世界の臨床試験管理システム市場は、コンポーネント、配信モード、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は、コンポーネントに基づいて2つのカテゴリに分かれています：ソフトウェアとサービスです。ソフトウェアは、臨床試験を効率的に管理する上で不可欠な役割を果たすため、主要コンポーネントとしてリードしています。サービスは、ソフトウェアの最適な利用を保証するために、導入、トレーニング、継続的なメンテナンスなどの重要なサポートを提供します。

市場は配信モード別では3つのカテゴリーに分けられます：ウェブベースCTMS、クラウドベースCTMS、オンプレミスCTMSです。クラウドベースのCTMSは、そのスケーラビリティとアクセシビリティにより優位に立ちます。WebベースのCTMSはユーザーフレンドリーなインターフェイスを提供し、オンプレミスのCTMSは厳しいデータセキュリティ要件を持つ組織に好まれ、第3位にランクされています。

臨床試験管理システム市場 - 地理的洞察

臨床試験管理システム（CTMS）市場は顕著な地理的動向を示しており、北米は確立されたヘルスケアインフラと高い研究開発投資によりリードしています。米国は世界の臨床試験の40%近くを占めており、FDAの臨床試験プログラムのような技術革新と患者アクセスを促進するイニシアチブが後押ししています。欧州は、厳格な規制要件と製薬企業や研究機関の協力的なアプローチに牽引され、その後に続いています。例えば、欧州医薬品庁（European Medicines Agency）は、臨床試験の承認プロセスの合理化を支援しています。アジア太平洋地域は、医療費の増加と患者数の増加、特に中国やインドのような臨床試験登録率が大幅に上昇している国々に後押しされ、急速に台頭しています。2022年、インドは臨床試験登録数が25％増加したと報告しましたが、これは研究の世界的ハブとなることへのコミットメントを反映しています。一方、ラテンアメリカや中東では、臨床研究能力の強化や海外投資の誘致を目的とした政府の取り組みに支えられ、CTMSソリューションが徐々に採用されつつあります。

臨床試験管理システム市場 - 競合情勢：

臨床試験管理システム（CTMS）市場の競合情勢は、さまざまな地域での活発な活動によって特徴付けられます。北米は依然としてトップランナーで、Medidata SolutionsやVeeva Systemsのような大手企業が進出しています。Veevaのクラウドベース・プラットフォームは世界で1,500以上の顧客をサポートしています。OracleやDassault Systemesのような企業は、欧州医薬品庁（European Medicines Agency）のような厳格な規制基準に対応するため、提供サービスを強化しています。アジア太平洋地域は、新興プレーヤーと臨床試験のアウトソーシングの増加によって急成長を遂げており、特にインドなどでは、Clinical Trials Registry-Indiaが2023年時点で45,000件を超える臨床試験の登録を報告しています。ラテンアメリカや中東では、多国籍製薬企業の誘致を目的としたブラジルの研究インフラへの投資など、臨床研究環境の改善を目的とした政府の取り組みに支えられ、現地企業が台頭し始めています。この競合情勢は、企業の技術革新と世界なプレゼンス拡大に伴い、絶えず進化しています。

目次

第1章 臨床試験管理システム市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 臨床試験管理システムの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 臨床試験管理システム業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 臨床試験管理システム市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 臨床試験管理システムの市場情勢

  • 臨床試験管理システム市場シェア分析、2023年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 臨床試験管理システム市場 - コンポーネント別

  • 概要
    • セグメントシェア分析：コンポーネント別
    • ソフトウェア
    • サービス

第8章 臨床試験管理システム市場 - 配信モード別

  • 概要
    • セグメントシェア分析：配信モード別
    • ウェブベースのCTMS
    • クラウドベースのCTMS
    • オンプレミスCTMS

第9章 臨床試験管理システム市場 - 用途別

  • 概要
    • セグメントシェア分析：用途別
    • 腫瘍学
    • 心血管疾患
    • 神経学
    • 感染症

第10章 臨床試験管理システム市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 製薬会社
    • 契約調査機関（CRO）
    • 医療機器企業
    • 学術・研究機関

第11章 臨床試験管理システム市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 臨床試験管理システム業界

  • 競合ダッシュボード
  • 企業プロファイル
    • ArisGlobal LLC
    • Bioclinica, Inc.
    • Bio - Optronics, Inc.
    • CRF Health Group Ltd.
    • DATATRAK International, Inc.
    • Forte Research Systems, Inc.（Advarra）
    • IBM Corporation
    • ICON plc
    • MasterControl, Inc.
    • Medidata Solutions, Inc.（Dassault Systemes）
    • MedNet Solutions, Inc.
    • Merge Healthcare Incorporated（IBM）
    • Oracle Corporation
    • Parexel International Corporation
    • RealTime Software Solutions, LLC
    • Veeva Systems Inc.
    • その他

第13章 アナリストの全方位展望

目次
Product Code: ANV3994

REPORT HIGHLIGHT

Clinical Trial Management System Market size was valued at USD 1,860.54 Million in 2023, expanding at a CAGR of 14.98% from 2024 to 2032.

The Clinical Trial Management System (CTMS) Market encompasses software solutions designed to streamline and manage clinical trials efficiently. The growing demand for efficient trial management and the increasing complexity of clinical studies are propelling the adoption of CTMS solutions. Regulatory compliance and the need for improved patient safety are also significant factors driving market growth. However, high implementation costs and the complexity of software integration pose challenges for smaller organizations. Opportunities exist in the expansion of clinical trials in emerging markets, where the demand for advanced healthcare solutions is rising. Notably, a survey by the Clinical Trials Transformation Initiative found that over 70% of clinical trial sponsors are investing in new technologies to enhance operational efficiency, indicating a robust shift towards digital solutions in trial management.

Clinical Trial Management System Market- Market Dynamics

Growing Demand for Efficient Trial Management Accelerates Clinical Trial Management System Market Expansion

The growing demand for efficient trial management is significantly accelerating the expansion of the Clinical Trial Management System (CTMS) Market. With the FDA reporting that over 70% of clinical trials experience delays due to inefficient management, organizations are increasingly adopting CTMS solutions to streamline processes. The National Institutes of Health (NIH) has also emphasized the importance of integrating technology to enhance data management and regulatory compliance. Companies like Medidata Solutions have noted that their platforms can reduce trial costs by up to 30%, making them an attractive option for sponsors. Moreover, a survey by the Clinical Trials Transformation Initiative revealed that 80% of clinical trial professionals believe that utilizing CTMS can enhance collaboration among stakeholders, ultimately leading to faster patient recruitment and improved trial outcomes. This urgent need for efficiency is driving healthcare organizations to invest in CTMS technologies to ensure they stay competitive in a rapidly evolving landscape.

Clinical Trial Management System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.98% over the forecast period (2024-2032)

Based on Component segmentation, the Software segment was predicted to show maximum market share in the year 2023

Based on Delivery Mode segmentation, Cloud-Based CTMS was the leading type in 2023

Based on Application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Clinical Trial Management System Market- Segmentation Analysis:

The Global Clinical Trial Management System Market is segmented on the basis of Component, Delivery Mode, Application, End-User, and Region.

The market is divided into two categories based on Components: Software and Services. Software leads as the primary component due to its essential role in managing trials efficiently. Services follow, providing crucial support for implementation, training, and ongoing maintenance to ensure optimal software utilization.

The market is divided into three categories based on Delivery Mode: Web-Based CTMS, Cloud-Based CTMS, and On-Premise CTMS. Cloud-based CTMS takes precedence due to its scalability and accessibility. Web-based CTMS follows, offering user-friendly interfaces, while On-Premise CTMS ranks third, preferred by organizations with stringent data security requirements.

Clinical Trial Management System Market- Geographical Insights

The Clinical Trial Management System (CTMS) Market exhibits notable geographical trends, with North America leading due to its established healthcare infrastructure and high R&D investment. The U.S. accounts for nearly 40% of global clinical trials, bolstered by initiatives like the FDA's Clinical Trial Program, promoting innovation and patient access. Europe follows closely, driven by stringent regulatory requirements and a collaborative approach among pharmaceutical companies and research institutions; for example, the European Medicines Agency supports streamlined processes for trial approvals. The Asia-Pacific region is rapidly emerging, fueled by increasing healthcare expenditures and a growing patient pool, particularly in countries like China and India, where trial enrollment rates are rising significantly. In 2022, India reported a 25% increase in clinical trial registrations, reflecting its commitment to becoming a global hub for research. Meanwhile, Latin America and the Middle East are gradually adopting CTMS solutions, supported by government initiatives aimed at enhancing clinical research capabilities and attracting foreign investments.

Clinical Trial Management System Market- Competitive Landscape:

The Competitive Landscape of the Clinical Trial Management System (CTMS) Market is characterized by significant activity across various regions. North America remains the frontrunner, home to major players like Medidata Solutions and Veeva Systems, which dominate due to their advanced technology and extensive client bases; for instance, Veeva's cloud-based platform supports over 1,500 customers worldwide. Europe follows closely, with companies like Oracle and Dassault Systemes enhancing their offerings to meet stringent regulatory standards, such as those set by the European Medicines Agency. The Asia-Pacific region is witnessing rapid growth, driven by emerging players and increased outsourcing of clinical trials, especially in countries like India, where the Clinical Trials Registry-India has reported over 45,000 registered trials as of 2023. In Latin America and the Middle East, local firms are beginning to emerge, supported by government initiatives aimed at improving clinical research environments, such as Brazil's investment in research infrastructure to attract multinational pharmaceutical companies. This competitive landscape is continually evolving as companies innovate and expand their global presence.

Recent Developments:

In June 2024, IQVIA launched the "One Home for Sites" platform, integrating clinical trial applications into a single dashboard to streamline operations for research sites. This aims to reduce technology overload, enhance productivity, and improve patient care in clinical trials.

In April 2022, Veeva Systems announced the global implementation of Veeva Vault CTMS at Bristol Myers Squibb, streamlining clinical trial management processes. This integration replaces legacy systems and aims to enhance efficiency in trial execution, completing the project in under 20 months.

In May 2024, EDETEK launched CONFORM(TM) eClinical Version 5.1, providing a comprehensive suite of integrated clinical trial management solutions. This platform includes Electronic Data Capture, Trial Management, and advanced monitoring tools, enhancing efficiency, data quality, and overall control for clinical trial sponsors.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ArisGlobal LLC
  • Bioclinica, Inc.
  • Bio-Optronics, Inc.
  • CRF Health Group Ltd.
  • DATATRAK International, Inc.
  • Forte Research Systems, Inc. (Advarra)
  • IBM Corporation
  • ICON plc
  • MasterControl, Inc.
  • Medidata Solutions, Inc. (Dassault Systemes)
  • MedNet Solutions, Inc.
  • Merge Healthcare Incorporated (IBM)
  • Oracle Corporation
  • Parexel International Corporation
  • RealTime Software Solutions, LLC
  • Veeva Systems Inc.
  • Others

GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services

GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY DELIVERY MODE- MARKET ANALYSIS, 2019 - 2032

  • Web-Based CTMS
  • Cloud-Based CTMS
  • On-Premise CTMS

GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Infectious Diseases

GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Medical Device Companies
  • Academic & Research Institutes

GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Trial Management System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Trial Management System Market Snippet by Component
    • 2.1.2. Clinical Trial Management System Market Snippet by Delivery Mode
    • 2.1.3. Clinical Trial Management System Market Snippet by Application
    • 2.1.4. Clinical Trial Management System Market Snippet by End-User
    • 2.1.5. Clinical Trial Management System Market Snippet by Country
    • 2.1.6. Clinical Trial Management System Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Trial Management System Key Market Trends

  • 3.1. Clinical Trial Management System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Trial Management System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Trial Management System Market Opportunities
  • 3.4. Clinical Trial Management System Market Future Trends

4. Clinical Trial Management System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Trial Management System Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Trial Management System Market Landscape

  • 6.1. Clinical Trial Management System Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Trial Management System Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. Clinical Trial Management System Market - By Delivery Mode

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Mode, 2023 & 2032 (%)
    • 8.1.2. Web-Based CTMS
    • 8.1.3. Cloud-Based CTMS
    • 8.1.4. On-Premise CTMS

9. Clinical Trial Management System Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Neurology
    • 9.1.5. Infectious Diseases

10. Clinical Trial Management System Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Contract Research Organizations (CROs)
    • 10.1.4. Medical Device Companies
    • 10.1.5. Academic & Research Institutes

11. Clinical Trial Management System Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Clinical Trial Management System Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Clinical Trial Management System Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Clinical Trial Management System Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Clinical Trial Management System Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Clinical Trial Management System Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Clinical Trial Management System Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. ArisGlobal LLC
    • 12.2.2. Bioclinica, Inc.
    • 12.2.3. Bio-Optronics, Inc.
    • 12.2.4. CRF Health Group Ltd.
    • 12.2.5. DATATRAK International, Inc.
    • 12.2.6. Forte Research Systems, Inc. (Advarra)
    • 12.2.7. IBM Corporation
    • 12.2.8. ICON plc
    • 12.2.9. MasterControl, Inc.
    • 12.2.10. Medidata Solutions, Inc. (Dassault Systemes)
    • 12.2.11. MedNet Solutions, Inc.
    • 12.2.12. Merge Healthcare Incorporated (IBM)
    • 12.2.13. Oracle Corporation
    • 12.2.14. Parexel International Corporation
    • 12.2.15. RealTime Software Solutions, LLC
    • 12.2.16. Veeva Systems Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us